Cytokine regulation in RA synovial tissue: role of T cell/macrophage contact-dependent interactions. by Brennan, F & Foey, A
S177
A glossary of specialist terms used in this chapter appears at the end of the text section. 
Available online http://arthritis-research.com/content/4/S3/S177
Historical background
It is now well accepted that the spontaneous production
of proinflammatory cytokines (in particular, tumour necro-
sis factor [TNF] and IL-1) produced locally in the inflamed
synovial joint contribute directly/indirectly to the pathogen-
esis of rheumatoid arthritis (RA) [1]. These observations
have arisen from ex vivo studies on human synovial cul-
tures, immunohistochemical and mRNA analysis of syn-
ovium, and in vivo studies in animal models of arthritis.
These investigations led to the development of several
TNF and IL-1 inhibitors, two of which are currently
licensed Remicade (chimeric anti-TNF antibody) and
Enbrel (TNF-receptor fusion protein). While such thera-
pies targeting TNF in chronic inflammatory disease are
very successful [2], it is also apparent that long-term
blockade of a cytokine such as TNF, which is important in
innate and acquired immunity, may lead to an increase in
latent and/or opportunistic infections. This is now appar-
ent, with a small but significant increase in unusual infec-
tions, as well as the re-emergence of latent tuberculosis,
particularly in Central and Eastern Europe [3].
There is thus a need to understand what mechanisms lead
to the production of proinflammatory cytokines in RA syn-
ovial tissue, and further to determine how this is linked to
homeostatic regulation. It has been observed that while
the production of proinflammatory cytokines and enzymes
is increased in RA, this is offset to some degree by the
action of the endogenous anti-inflammatory cytokines and
cytokine inhibitors. Of particular importance in this respect
is IL-10, an important regulator of TNF-α and IL-1β sponta-
neously produced by macrophages in the rheumatoid joint
[4,5]. Thus, if endogenous IL-10 is blocked in RA synovial
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cell cultures, the spontaneous production of both TNF and
IL-1 increases significantly [4]. There is therefore an
important need to develop therapies that block proinflam-
matory pathways but leave unaffected those pathways
that regulate immunoregulatory cytokines such as IL-10.
Cognate-dependent interactions
Histological studies of synovium in RA have indicated that
this tissue is very cellular, and that several different cell
types including macrophages and T cells are in close
proximity [6]. This may suggest that contact signals
between macrophages and T cells could be of importance
in vivo in modulating macrophage function. We have
found that TNF-α production in RA synovium is T-cell
dependent, as removal of CD3-positive T cells from RA
synovial mononuclear cells resulted in significant reduced
macrophage TNF-α production [7]. Furthermore, this
signal was abrogated if physical contact between the two
cell types was blocked.
Direct-contact-mediated interactions have been studied
by several groups using transformed T-cell lines and
monocytic lines, and have been found to play a role in
inducing the synthesis of several cytokines including IL-1β,
TNF-α, IL-10 and metalloproteinases [8–12]. We have
studied T cell/monocyte cognate interactions using cells
isolated from the peripheral blood of normal donors.
Importantly, we observed that the manner in which T cells
were activated influenced the profile of cytokines induced
in the monocytes. Thus, if blood T cells were activated
with cross-linked anti-CD3, this induced the production of
TNF-α and IL-10 in monocytes [12]. However, if the
T cells were stimulated with a cocktail of cytokines
(TNF-α, IL-2 and IL-6) for 8 days (bystander activation),
TNF-α production followed but IL-10 production did not
[11]. These observations suggested to us that cytokine-
stimulated T cells (Tck) may be the actual T cells in RA
synovial tissue that induce macrophage TNF-α production,
because they induce an unbalanced, proinflammatory
cytokine response from monocytes and they could be part
of a vicious cycle (Fig. 1). Indeed, in addition to the mech-
anism of T-cell activation determining the cytokine profile
produced by monocytic cells, the corresponding T-cell
phenotype would also appear to be important, as one
study [13] suggested a differential regulation of mono-
cyte-derived cytokine production by Th1-like and Th2-like
cells. This study describes CD4+ Th1 clones inducing
high levels of IL-1β production by THP-1 monocytes,
whereas Th2 clones induced higher levels of IL-1ra. This
implies that Th1 cells are proinflammatory whereas Th2
cells are anti-inflammatory.
The hypothesis that RA T cells mimic the action of Tck
cells is attractive since T cells found in RA synovium have
unusual characteristics. The T cells are relatively small and
noncycling, but have features of activation, with over one-
half expressing HLA class II, VLA antigens, CD25 and
CD69 [14,15]. T-cell receptor analysis has not revealed a
consistent pattern, and responses to putative autoanti-
gens have not been easy to reproduce (reviewed in [16]).
Based on these features and the low capacity of T cells to
produce T-cell-derived cytokines, it has been proposed
that T cells in the joint may not be involved in the later
stages of the disease [17]. We have, however, proposed
that they are involved in disease pathology through the
activation of macrophages to induce TNF. The environ-
ment of the RA synovium is favourable to Tck cells, as it is
rich in cytokines. Unutmaz et al. described bystander-acti-
vated T cells generated from normal peripheral blood
mononuclear cells (PBMC) with IL-2, IL-6 and TNF-α [18].
We found that IL-15 could, by itself, mimic the IL-6/TNF-α/
IL-2 cocktail used to activate Tck [11]. IL-15 is of particu-
lar interest as it is found in RA synovium [19] and can acti-
vate peripheral blood T cells to induce TNF-α synthesis in
U937 cells or in adherent RA synovial cells in a contact-
dependent manner [20,21]
Other cognate cell-to-cell interactions occur in the syn-
ovial joint, which contribute to the disease pathology
observed in RA. These interactions include endothelial
cell/T cell and fibroblast/T cell interactions. During the
early stages of inflammation there is a large cellular infiltra-
tion from the peripheral circulation to the synovial joint,
where interactions between T cells and vascular endothe-
lium drive further extravasation and infiltration by the
expression of cell adhesion molecules, chemokines and
cytokines [22–25]. In addition, the earliest infiltrating cells,
neutrophils, can be activated by contact-mediated inter-
action with T cells, as determined by the ability of these
neutrophils to be primed for respiratory burst by formyl-
methionine leucine phenylalanine peptide [26].
As the pathology of RA progresses to chronic inflamma-
tion and pannus forms at the cartilage–pannus junction,
Figure 1
Cytokine disequilibrium induced by cytokine-stimulated T cells (Tck).
Mφ, monocytes; Ttcr, T-cell-receptor-dependent stimulated T cells.
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the interactions between T cells and fibroblasts/
macrophages predominate. The interaction between stim-
ulated T cells and dermal fibroblasts or synoviocytes has
recently been shown to induce MMP-1 (collagenase) and
TIMP-1, with an imbalance in favour of the proinflammatory
MMP-1 [27], also inhibiting the synthesis of type I and
type III collagen by fibroblast cells [28].
Studies undertaken thus far have documented the potent
stimulatory activity of T cells on monocyte cytokine pro-
duction during the pathology of RA. The abundance of
T cells and monocytes in the peripheral circulation, which
have the potential to physically interact with each other,
however, does not seem to induce cytokine production.
This led to the hypothesis and subsequent characterisa-
tion of an inhibitory factor, apolipoprotein A-1, preventing
monocyte activation in the plasma/serum [29]. The pres-
ence of apolipoprotein A-1 and subsequent inhibition of
T-cell-mediated macrophage activation may suggest this
molecule to have a useful anti-inflammatory therapeutic
effect in chronic inflammatory diseases such as RA.
Cell surface molecules
As contact-dependent signals have been demonstrated to
be of importance, much attention has focused on the
probable candidate molecules on the surface of cells
mediating these functions. Specific surface interaction
molecules that have been reported to mediate induction of
monocyte cytokine synthesis include CD69, LFA-1 [8,30],
CD44 [31], CD45 [32], CD40 [33], membrane TNF [12],
and signalling lymphocytic activation molecule [34]. Our
studies further demonstrated that T cells activated through
the T-cell receptor complex induced monocyte IL-10 syn-
thesis, which was partially dependent on endogenous
TNF-α and IL-1, and that T-cell membrane TNF-α was an
important contact-mediated signal [12,35]. However,
IL-10 synthesis still occurred when TNF-α and IL-1 were
neutralised, suggesting that there are other TNF/IL-1-inde-
pendent signals required for IL-10 synthesis.
While TNF clearly plays a role in IL-10 production, there
are other signals independent of TNF and IL-1 that may be
involved. Of particular interest are members of the
TNF/TNF-receptor family, which include CD40, CD27,
CD30, OX-40 and LTβ. The ligands of these TNF-receptor
molecules have been described as upregulated on T-cell
activation. In addition, CD40L, 4-1BB, CD27L and CD30
have been described to be released as soluble molecules
after activation [36–39]. The interaction between CD40L
and CD40 has been suggested to be important for induc-
ing both IL-1 and IL-12 synthesis following T-cell inter-
action with monocytes [33,40] and, more recently, to
mediate IL-10 production by human microglial cells on
interaction with anti-CD3-stimulated T cells [41]. In addi-
tion, we have recently shown that CD40L/CD40 interac-
tion mediates cognate induction of macrophage IL-10
[42]. The potential involvement of these ligand/counter
ligand pairs on cells interacting in synovial membrane
tissue is represented in Figure 2.
Differentiation status
In addition to the stimulus encountered by the T cells, our
data has indicated the importance of the differentiation
state of the monocyte in determining cytokine profiles in
response to activated T cells. We observed that CD40
signalling augmented lipopolysaccharide (LPS)-induced
IL-10 production by monocytes, but also observed that
CD40 ligation induced IL-10 production by differentiated
monocytes (macrophages) in the absence of LPS. Indeed,
the priming mechanism of the macrophage determined the
cytokine profile: macrophage-colony-stimulating factor
preprogrammed macrophages to produce both IL-10 and
TNF-α on stimulation by CD40L or Tck, whereas IFN-γ
priming resulted predominantly in TNF-α [42].
IFN-γ-primed macrophages, however, can produce an
endogenous IL-10 activity that is not secreted into the
supernatant on cell contact with either Tck or CD40L
transfectants, as neutralisation of endogenous IL-10
resulted in a marked increase in TNF-α production. This
observation may agree with the report of membrane-
associated IL-10 [43] and may highlight differences in the
ability of these two types of macrophage-like cells to
process cytokines.
Macrophage-colony-stimulating factor can usually be
readily detected in the RA joint, while IFN-γ is scarce
(reviewed in [44]). This may indicate why both TNF-α and
Available online http://arthritis-research.com/content/4/S3/S177
Figure 2
Potential ligand/counter ligand interactions involved in cytokine
production by macrophages. HLA-DR, human leukocyte antigen —
class II, subtype DR; ICAM, intracellular adhesion molecule; 
LT, lymphotoxin; MMP, matrix metalloproteinase; OPN, osteoprotegrin;
RNI, reactive nitrogen intermediates; TCR, T-cell receptor; TNF, tumour
necrosis factor.
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IL-10 are found in synovial membrane cell cultures. This
preprogramming of macrophages would appear to be irre-
spective of the triggering stimulus because macrophages
stimulated by either Tck, CD40 ligation or LPS result in
similar cytokine profiles. It would thus appear that the
route of differentiation of the monocyte is critical in the
induction of IL-10 in cognate interactions between acti-
vated T cells and macrophages.
Signalling pathways
TNF-α synthesis in monocytes in response to some stimuli
(LPS) but not others (zymosan or CD45 ligation) is NF-κB
dependent [32,45,46]. It is thus of interest to observe that
Tck-induced, but not T-cell-receptor-dependent stimulated
T cell (Ttcr)-induced, TNF-α production in monocytes is
NF-κB dependent. Furthermore, whereas phosphatidyl-
inositol 3-kinase (PI3K) inhibitors blocked Ttcr induction of
TNF-α, they paradoxically augmented TNF-α in monocytes
stimulated by Tck cells. Importantly, we then found that RA
T cells behaved like Tck cells, in that the induction of
TNF-α in resting peripheral blood monocytes was NF-κB
dependent but superinduced if PI3K was blocked. An
identical result was observed if NF-κB or PI3K was
blocked in the RA synovial cell cultures.
IL-10 production in monocytes/macrophages is equally
complex. In response to LPS, IL-10 production is depen-
dent on endogenous IL-1 and TNF-α. Furthermore, there
is selective mitogen-activated protein kinase (MAPK) utili-
sation where IL-10 production was dependent on p38
MAPK, and TNF-α production was dependent on both
p38 MAPK and p42/44 MAPK [47]. The involvement of
p38 MAPK activity in IL-10 production subsequently led to
the characterisation of the downstream effector, hsp27, as
an anti-inflammatory mediator [48].
Little is known, however, regarding the involvement of the
PI3K pathway in macrophage production of IL-10. PI3K
and its downstream substrate p70S6K mediate IL-10-
induced proliferative responses but not anti-inflammatory
effects [49]. A recent study from our laboratory has
described Tck-induced macrophage IL-10 production to
be dependent on PI3K and p70S6K, whereas TNF-α pro-
duction is negatively regulated by PI3K and is p70S6K
dependent [50]. This suggests that IL-10 and TNF-α share
a common component, p70S6K, but differentially utilise
PI3K activity. These results are reproduced in the sponta-
neous cytokine production by RA synovial mononuclear
cells (RA-SMCs) and by cocultures of RA synovial T cells
with macrophages (RA-T/macrophage cocultures), further
suggesting the relevance of this Tck/macrophage cognate
coculture system as a model for cytokine production occur-
ring in the inflamed synovium of the rheumatoid joint.
Although many other studies have implicated other sig-
nalling cascades in the induction of IL-10 production, not
much work exists on the signalling required in
macrophages stimulated by cognate interactions with
fixed activated T cells. PKC and cAMP signalling have
been implicated in IL-10 and TNF-α production and are
currently under investigation in our group. Preliminary
results would suggest that both these cascades differen-
tially regulate IL-10 and TNF-α.
Studies undertaken by other groups have reported the
involvement of the cAMP/PKA pathway in the induction of IL-
10 production by human PBMC. The membrane-permeable
dibutyryl cAMP was capable of elevating IL-10 mRNA and of
augmenting LPS-induced IL-10 production, but on its own
was incapable of producing IL-10 protein [51]. This work
also demonstrated a role for PKC in the induction of IL-10 by
LPS using the PKC inhibitors, calphostin C and H-7. This
result contradicts our data but may reflect that this study
used PBMC, a heterogeneous population, as compared with
purified monocyte-derived macrophages.
In addition, the selective inhibition of phosphodiesterase
type IV by rolipram was found to augment LPS-induced
IL-10 production by murine peritoneal macrophages. The
mechanism of this was thought to be as a consequence of
LPS inducing the anti-inflammatory mediator,
prostaglandin E2, which in turn upregulates intracellular
cAMP via stimulation of adenylate cyclase activity [52].
Concluding remarks
The cognate activation of macrophages by T cells has
focused almost exclusively on the membrane interactions
mediating the macrophage effector function, such as nitric
oxide release, phagocytosis, B-cell help and, more recently,
the cytokine profiles induced. The control of T-cell-induced
IL-10 and TNF-α production by monocyte-derived macro-
phages is complex and is regulated at many levels. These
levels include priming of the monocyte/macrophage, T-cell
stimulation, and hence specific ligand/receptor interaction,
and the resulting signal cascades and crosstalk between
them. The continued study of these contact-mediated inter-
actions, the signal transduction distal to the receptor and
how they compare between the induction of IL-10 and
TNF-α may discover potential therapeutic targets selec-
tively affecting proinflammatory TNF-α production without
affecting anti-inflammatory IL-10 production. Such targets
will prove to be of great benefit in the treatment of such
chronic inflammatory diseases as RA.
Glossary of terms
MAPK = mitogen-activated protein kinase; PI3K = phos-
phatidylinositol 3-kinase; Tck = cytokine-stimulated T cells;
Ttcr = T-cell-receptor-dependent stimulated T cells.
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